IGM Biosciences Inc - Ordinary Shares
News
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
Globe Newswire MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...\n more…
Head-To-Head Contrast: IGM Biosciences (NASDAQ:IGMS) versus Journey Medical (NASDAQ:DERM)
Zolmax Journey Medical (NASDAQ:DERM - Get Free Report) and IGM Biosciences (NASDAQ:IGMS - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the...\n more…
HC Wainwright Weighs in on IGM Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:IGMS)
Ticker Report IGM Biosciences, Inc. (NASDAQ:IGMS - Free Report) - Equities research analysts at HC Wainwright raised their Q3 2024 earnings per share estimates for shares of IGM Biosciences in a research note...\n more…
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 4.4% After Analyst Downgrade
Ticker Report IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report)'s stock price fell 4.4% on Thursday after HC Wainwright lowered their price target on the stock from $12.00 to $11.00. HC Wainwright currently...\n more…